fda changes to tirzepatide Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management FDA Announces End To Compounded

Dietary and lifestyle modifications are typically the first-line approach: Eat smaller, more frequent meals rather than large portions Avoid lying down for at least two to three hours after eating Elevate the head of the bed by 1520 cm if nocturnal symptoms are present Reduce or avoid known reflux triggers such as fatty or spicy foods, caffeine, alcohol, and carbonated drinks Maintain a healthy weight, as excess abdominal weight increases intra-abdominal pressure Pharmacological management may also be appropriate in some cases

Education about the actual risks versus perceived dangers helps improve medication adherence and reduces unnecessary concern that might lead to treatment discontinuation

Your PlexusDx provider can review your complete health history and adjust your treatment plan accordingly

Bareford, L